Acquisition Opportunity Degge Group was acquired by PharmaLex Group in 2017, indicating potential integration or collaboration opportunities within a larger pharma services ecosystem to expand risk management, pharmacovigilance, and safety analytics capabilities.

Small Firm Focus With 11-50 employees and revenue in the 1M-10M range, Degge represents a lean, specialized partner for targeted safety and pharmacoepidemiology projects, suggesting a need for scalable service add-ons or retainer-based engagements.

Regulatory SAAS Readiness Tech stack includes OneTrust and JSON-LD with a WordPress site, indicating familiarity with governance, data privacy compliance, and structured data; opportunities exist to offer integrated compliance, data management, and digital solutions.

Industry Footprint Active in pharmacovigilance, pharmacoeconomics, and outcomes research since 1988, plus presence at major conferences, signaling readiness for partnerships in long-term safety analytics, REMS/RMP support, and real-world evidence initiatives.

Growth Signals Recent acquisition news featuring PharmaLex strengthening US presence suggests consolidation and potential cross-sell or up-sell opportunities for safety and risk management services across a larger commercial platform.